MAXHEALTH

Technical Analysis

MAX Healthcare is currently testing a key ascending trendline support that has held since mid-March 2025, reflecting a strong uptrend over the past few months. After a recent sharp rally toward ₹1,250, the stock has faced selling pressure and is now hovering around ₹1,166, marginally below the trendline, suggesting a potential breakdown. The volume on the latest red candle is relatively moderate, indicating a cautious pullback rather than panic selling. A decisive close below ₹1,150 with higher volume could confirm trendline breakdown and trigger further downside toward the ₹1,100–1,080 support zone, whereas a bounce from current levels would keep the bullish structure intact.